News & Events
29 June 2024
PREFERABLE at the MASCC Annual Meeting
We are delighted to announce the presentation of final results of the PREFERABLE project during a workshop, at the MASCC congress in Lille on June 29th 2024!
 READ MORE
4 June 2024
Our exercise program is also cost-effective
Is a 9-month exercise program for patients with metastatic breast cancer likely to be cost-effective? Yes!
 READ MORE
31 May 2024
Exciting PREFERABLE Project Findings Presented in Boston
Last week, we presented the PREFERABLE project results at the ACSM 2024 conference in Boston.
 READ MORE
Collaboration

PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.